Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full – 2013) http://journals.lww.com/anesthesia-a...Induce.31.aspx
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Diuretic effects of cannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits (full – 2013)http://www.actaps.com.cn/qikan/manag.../2013-2-03.pdf
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/r...o-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23414569
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23499687
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23587650
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23643752
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23673278
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23796670
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23892011
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23908133
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23960212
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24055516
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24062073
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24120553
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24148812
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24304686
The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24342802
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst – 2013) http://www.sciencedirect.com/science...41008X13004766
Diuretic effects of cannabinoid agonists in mice (abst – 2013) http://www.sciencedirect.com/science...14299913007176
Cannabinoid Trans-Caryophyllene Protects Brain Cells From Ischemia (news – 2013) http://www.medicalnewstoday.com/articles/256799.php
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news – 2013)http://www.sciencedaily.com/releases...0221141140.htm
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts (full – 2014) http://journal.frontiersin.org/Journ...014.00100/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF- 2014)http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24854955
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853387
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24930711
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
Differential Activation of Intracellular vs Plasmalemmal CB2 Cannabinoid Receptors (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25033246
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25079058
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full – 2013) http://journals.lww.com/anesthesia-a...Induce.31.aspx
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Diuretic effects of cannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits (full – 2013)http://www.actaps.com.cn/qikan/manag.../2013-2-03.pdf
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/r...o-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23414569
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23499687
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23587650
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23643752
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23673278
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23796670
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23892011
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23908133
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23960212
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24055516
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24062073
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24120553
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24148812
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24304686
The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24342802
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst – 2013) http://www.sciencedirect.com/science...41008X13004766
Diuretic effects of cannabinoid agonists in mice (abst – 2013) http://www.sciencedirect.com/science...14299913007176
Cannabinoid Trans-Caryophyllene Protects Brain Cells From Ischemia (news – 2013) http://www.medicalnewstoday.com/articles/256799.php
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news – 2013)http://www.sciencedaily.com/releases...0221141140.htm
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts (full – 2014) http://journal.frontiersin.org/Journ...014.00100/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF- 2014)http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24854955
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853387
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24930711
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
Differential Activation of Intracellular vs Plasmalemmal CB2 Cannabinoid Receptors (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25033246
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25079058